시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 심폐 부하 시험 시스템 시장 보고서(2025년)
Cardiopulmonary Stress Testing Systems Global Market Report 2025
상품코드 : 1682023
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 200 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,183,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 8,938,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,692,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

심폐 부하 시험 시스템 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년 연평균 성장률(CAGR)은 5.4%로 71억 7,000만 달러로 성장합니다. 예측 기간의 성장은 맞춤형 의료 및 정밀의료, 원격 환자 모니터링 및 원격의료, 예방 의료의 중요성, 집단건강관리 노력, 신흥 시장으로의 확대 등에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 무선 기술 통합, 휴대용 및 소형 검사 시스템의 채택, 소프트웨어 솔루션의 발전, 예방 의료에 대한 관심 증가, 원격의료 및 원격 모니터링 기능의 확대, 인공지능의 통합, 새로운 스트레스 검사 프로토콜의 개발 등이 있습니다.

심혈관 질환의 유병률 증가는 향후 심폐 부하 테스트 시스템 시장의 성장을 가속할 것으로 예상됩니다. 심혈관 질환(CVD)은 심장과 혈관에 영향을 미치는 질환군입니다. 심혈관 질환의 유병률 증가의 원인으로는 건강에 해로운 식습관, 운동 부족, 도시화 등을 들 수 있습니다. 심폐 부하 테스트 시스템은 운동 중 심장 및 폐 기능을 평가하여 심혈관 건강을 평가합니다. 환자의 기능적 능력과 심혈관계의 한계에 맞는 개별화된 운동 프로그램을 처방할 수 있는 귀중한 정보를 제공합니다. 예를 들어 미국 질병통제예방센터(CDC)에 따르면 2023년 6월 미국 성인의 약 48%가 심혈관 질환을 앓고 있으며, 특히 관상동맥질환(CAD)은 약 1,250만 명에 달할 것으로 예상하고 있습니다. 따라서 심혈관 질환의 유병률 증가가 심폐 부하 테스트 시스템 시장의 성장을 주도하고 있습니다.

심폐 부하 테스트 시스템 시장의 주요 기업은 휴대용 ECG와 같은 혁신적인 제품을 개발하여 시장 매출을 주도하고 있습니다. 휴대용 심전도는 이동 중에도 심장의 전기적 활동을 기록할 수 있는 장비를 말합니다. 예를 들어 미국에 본사를 둔 의료기기 및 AI 기업 얼라이브코어(AliveCor)는 2022년 2월 세계 최초의 신용카드 크기의 개인용 심전도 기기인 KardiaMobile Card를 출시했습니다. 지갑에 넣을 수 있을 정도로 얇고, 30초 만에 의료용 싱글 리드 심전도를 측정합니다. 이 장비는 FDA 승인을 받았으며, 심방세동, 서맥, 빈맥을 포함한 다양한 심장 상태를 감지할 수 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 대기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSA
영문 목차

영문목차

Cardiopulmonary stress testing systems are sophisticated diagnostic tools used in healthcare settings to evaluate the performance of the cardiovascular and respiratory systems under stress. These tests are valuable in designing individualized exercise prescriptions, assessing treatment effectiveness, and predicting prognosis in patients with cardiovascular and respiratory diseases.

The main product types of cardiopulmonary stress testing systems are cardiopulmonary exercise testing (CPET) systems, stress ECG, pulse oximeters, single-photon emission computed tomography (SPECT), and stress blood pressure monitors. Cardiopulmonary exercise testing (CPET) systems refer to a type of product used to evaluate the overall efficiency of a patient's cardiovascular and pulmonary systems. These are used in various applications such as oxygen uptake, carbon dioxide, minute ventilation, and anaerobic thresholds and also by various end users such as hospitals, specialty clinics/cardiology clinics, ambulatory surgical centers, and diagnostic centers.

The main product types of cardiopulmonary stress testing systems are cardiopulmonary exercise testing (CPET) systems, stress ECG, pulse oximeters, single-photon emission computed tomography (SPECT), and stress blood pressure monitors. Cardiopulmonary exercise testing (CPET) systems refer to a type of product used to evaluate the overall efficiency of a patient's cardiovascular and pulmonary systems. These are used in various applications such as oxygen uptake, carbon dioxide, minute ventilation, and anaerobic thresholds and also by various end users such as hospitals, specialty clinics/cardiology clinics, ambulatory surgical centers, and diagnostic centers.

The cardiopulmonary stress testing systems market size has grown strongly in recent years. It will grow from $5.43 billion in 2024 to $5.8 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to rise in cardiovascular and respiratory diseases, aging population, healthcare infrastructure development, awareness and prevention initiatives, reimbursement policies and healthcare spending.

The cardiopulmonary stress testing systems market size is expected to see strong growth in the next few years. It will grow to $7.17 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to personalized medicine and precision healthcare, remote patient monitoring and telemedicine, emphasis on preventive healthcare, population health management initiatives, expansion into emerging markets. Major trends in the forecast period include integration of wireless technology, adoption of portable and compact testing systems, advancements in software solutions, growing emphasis on preventive healthcare, expansion of telehealth and remote monitoring capabilities, integration of artificial intelligence, development of novel stress testing protocols.

The increasing prevalence of cardiovascular diseases is expected to propel the growth of the cardiopulmonary stress testing systems market going forward. Cardiovascular diseases (CVDs) are a group of disorders affecting the heart and blood vessels. The reasons for increasing prevalence of cardiovascular diseases include unhealthy diet, physical inactivity, and urbanization. Cardiopulmonary stress testing systems assess cardiovascular health by evaluating cardiac and pulmonary function during exercise. It provides valuable information for prescribing individualized exercise programs tailored to a patient's functional capacity and cardiovascular limitations. For instance, in June 2023, according to the Centers for Disease Control and Prevention (CDC), a US-based national public health agency of the United States, approximately 48% of adults in the United States have some form of cardiovascular disease, with around 12.5 million experiencing coronary artery disease (CAD) specifically. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the cardiopulmonary stress testing systems market.

Major companies in the cardiopulmonary stress testing system market are developing innovative products such as portable ECG to drive revenues in the market. Portable ECG refers to a device that can be used to record the electrical activity of the heart while on the go. For instance, in February 2022, AliveCor, a US-based medical device and AI company, launched the KardiaMobile Card, which is the world's first credit-card-sized personal ECG device. It is slim enough to fit into a wallet and delivers a medical-grade, single-lead ECG in 30 seconds. The device is FDA-cleared and can detect various heart conditions, including AFib, bradycardia, and tachycardia.

In May 2024, WearLinq, a US-based health technology company specializing in wearable devices for monitoring cardiac health, acquired AMI Cardiac Monitoring LLC for an undisclosed amount. This acquisition enhances WearLinq's capacity to deliver comprehensive clinical services nationwide and expand patient access to its eWave 6-lead wearable ECG monitor, which recently received FDA 510(k) clearance. AMI Cardiac Monitoring is a US-based healthcare technology company that provides advanced cardiac monitoring solutions. This acquisition is expected to strengthen WearLinq's position in the growing wearable health device market, particularly in the cardiac health sector.

Major companies operating in the cardiopulmonary stress testing systems market are Cardinal Health Inc., General Electric, Thermo Fisher Scientific Ltd., Siemens Healthineers AG, Becton Dickinson and Co., Koninklijke Philips N.V., GE Healthcare, Hill-rom Holdings Inc., Masimo Corporation, Halma plc, Nihon Kohden Corporation, OSI Systems Inc., Welch Allyn, Fukuda Denshi Co. Ltd., Spacelabs Healthcare, Schiller AG, Vyaire Medical Inc., Nonin Medical Inc., MGC Diagnostic Corporation, SunTech Medical Inc., COSMED srl, Allengers Medical Systems Ltd., Nasiff Associates Inc., CareFusion Corporation (BD), Clarity Medical

North America was the largest region in the cardiopulmonary stress testing systems market in 2024. The regions covered in the cardiopulmonary stress testing systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiopulmonary stress testing systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cardiopulmonary stress testing systems market consists of sales of specialized systems, metabolic carts, and portable devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiopulmonary Stress Testing Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiopulmonary stress testing systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for cardiopulmonary stress testing systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cardiopulmonary stress testing systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Cardiopulmonary Stress Testing Systems Market Characteristics

3. Cardiopulmonary Stress Testing Systems Market Trends And Strategies

4. Cardiopulmonary Stress Testing Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cardiopulmonary Stress Testing Systems Growth Analysis And Strategic Analysis Framework

6. Cardiopulmonary Stress Testing Systems Market Segmentation

7. Cardiopulmonary Stress Testing Systems Market Regional And Country Analysis

8. Asia-Pacific Cardiopulmonary Stress Testing Systems Market

9. China Cardiopulmonary Stress Testing Systems Market

10. India Cardiopulmonary Stress Testing Systems Market

11. Japan Cardiopulmonary Stress Testing Systems Market

12. Australia Cardiopulmonary Stress Testing Systems Market

13. Indonesia Cardiopulmonary Stress Testing Systems Market

14. South Korea Cardiopulmonary Stress Testing Systems Market

15. Western Europe Cardiopulmonary Stress Testing Systems Market

16. UK Cardiopulmonary Stress Testing Systems Market

17. Germany Cardiopulmonary Stress Testing Systems Market

18. France Cardiopulmonary Stress Testing Systems Market

19. Italy Cardiopulmonary Stress Testing Systems Market

20. Spain Cardiopulmonary Stress Testing Systems Market

21. Eastern Europe Cardiopulmonary Stress Testing Systems Market

22. Russia Cardiopulmonary Stress Testing Systems Market

23. North America Cardiopulmonary Stress Testing Systems Market

24. USA Cardiopulmonary Stress Testing Systems Market

25. Canada Cardiopulmonary Stress Testing Systems Market

26. South America Cardiopulmonary Stress Testing Systems Market

27. Brazil Cardiopulmonary Stress Testing Systems Market

28. Middle East Cardiopulmonary Stress Testing Systems Market

29. Africa Cardiopulmonary Stress Testing Systems Market

30. Cardiopulmonary Stress Testing Systems Market Competitive Landscape And Company Profiles

31. Cardiopulmonary Stress Testing Systems Market Other Major And Innovative Companies

32. Global Cardiopulmonary Stress Testing Systems Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiopulmonary Stress Testing Systems Market

34. Recent Developments In The Cardiopulmonary Stress Testing Systems Market

35. Cardiopulmonary Stress Testing Systems Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기